Objectives: This study aims to provide real-time surveillance of epidemiological outbreaks of avian influenza in humans and mammals. The primary objective is to understand and track the dynamics of outbreaks as they develop, facilitating timely interventions and informed public health decisions. The data collection is part of a broader initiative focused on improving preparedness and response capabilities to emerging health threats.
Data Description: The dataset includes comprehensive and up-to-date information on epidemiological patterns, including geographic spread, incidence rates, and demographic factors. Collected through systematic monitoring and reporting systems, this dataset is invaluable to researchers seeking to understand the evolving nature of avian influenza outbreaks in the global context. By sharing these data, we aim to contribute to the collective knowledge base by supporting evidence-based strategies for effective public health management and intervention.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881443 | PMC |
| http://dx.doi.org/10.1186/s13104-024-07042-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
Virology
March 2025
ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune 411001, India.
H5N1 viruses belonging to clade 2.3.4.
View Article and Find Full Text PDFInfluenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
J Immunol
January 2025
Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, United States.
Current influenza vaccines are not effective in conferring protection against antigenic variants and pandemics. To improve cross-protection of influenza vaccination, we developed a 5xM2e messenger RNA (mRNA) vaccine encoding the tandem repeat conserved ectodomain (M2e) of ion channel protein M2 derived from human, swine, and avian influenza A viruses. The lipid nanoparticle (LNP)-encapsulated 5xM2e mRNA vaccine was immunogenic, eliciting high levels of M2e-specific IgG antibodies, IFN-γ+ T cells, T follicular helper cells, germinal center phenotypic B cells, and plasma cells.
View Article and Find Full Text PDFWe measured stability of infectious influenza A(H5N1) virus in irradiated raw milk and wastewater and on surfaces. We found a relatively slow decay in milk, indicating that contaminated milk and fomites pose transmission risks. Although the risk is low, our results call for caution in milk handling and disposal from infected cattle.
View Article and Find Full Text PDFCases of high-consequence infectious diseases identified in the UK, 1962-2023.
J Med Microbiol
March 2025
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, UK.
The management of patients with acute infectious diseases can present significant challenges, especially if the causative agent has a propensity for person-to-person transmission. In such cases, effective patient management is dependent on both rapid identification of disease and the provision of necessary medical care while adhering to suitable infection prevention and control measures to reduce the potential for onwards transmission. The UK has operated a defined system for managing patients with high-consequence infectious diseases (HCIDs) since the 1970s, when protocols were first implemented following the first descriptions of several viral haemorrhagic fever diseases, including Marburg virus disease, Lassa fever and Ebola virus disease (EVD).
View Article and Find Full Text PDFH5N1 influenza A virus: lessons from past outbreaks and emerging threats.
Infez Med
March 2025
Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.
The first highly pathogenic H5N1 emerged in 1959 on a chicken farm in Scotland. The ancestor of the strains presently circulating was isolated in 1996 from a domestic goose in China. Since 1997, more than 900 severe human infections have been reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!